Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Buy
3,109
+24
+0.8% +$8.56K 0.29% 61
2025
Q4
$1.01M Buy
3,085
+54
+2% +$17.1K 0.27% 64
2025
Q3
$855K Buy
3,031
+60
+2% +$17.4K 0.23% 73
2025
Q2
$830K Buy
2,971
+51
+2% +$14.4K 0.24% 70
2025
Q1
$910K Sell
2,920
-269
-8% -$79.4K 0.3% 64
2024
Q4
$831K Buy
3,189
+81
+3% +$24K 0.26% 68
2024
Q3
$1M Buy
3,108
+18
+0.6% +$5.89K 0.29% 65
2024
Q2
$965K Buy
3,090
+269
+10% +$79K 0.31% 63
2024
Q1
$802K Hold
2,821
0.27% 68
2023
Q4
$813K Hold
2,821
0.3% 63
2023
Q3
$761K Sell
2,821
-28
-1% -$6.99K 0.3% 64
2023
Q2
$633K Buy
2,849
+19
+0.7% +$4.41K 0.25% 70
2023
Q1
$684K Hold
2,830
0.3% 62
2022
Q4
$743K Buy
+2,830
New +$759K 0.39% 59

Other funds holding AMGN

Carr Financial Group's AMGN Position: Q1 2026 in Review

Carr Financial Group increased its Amgen (AMGN) stake by 0.78% in Q1 2026, buying an estimated $8.56K and bringing the position to 3,109 shares worth $1.09M. The position accounts for 0.29% of the portfolio, ranked #61.

Carr Financial Group first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Carr Financial Group held 3,109 shares of Amgen worth $1.09M as of Q1 2026.
  • Carr Financial Group bought 24 Amgen shares in Q1 2026, an estimated $8.56K.
  • Amgen made up 0.29% of Carr Financial Group's portfolio in Q1 2026, its #61 holding.
  • Carr Financial Group first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Carr Financial Group's 13F filing for Q1 2026, filed 12 May 2026.